Vnitr Lek 2019, 65(7-8):524-526 | DOI: 10.36290/vnl.2019.091

Diosmin - still an important modality in the treatment of venous insufficiency

Jiří Slíva
Ústav farmakologie 3. LF UK, Praha

Chronic venous insufficiency is a highly prevalent disease in the western population. Unfortunately, there is no causal treatment yet. A key role in the recommended therapeutic approaches, especially in the early stages, is the compression therapy accompanied by pharmacotherapy. This includes, inter alia, micronized diosmin. The following text summarizes the basic knowledge of its properties that determine its clinical use.

Keywords: diosmin; flavonoids; chronic venous insufficiency; micronization

Received: July 26, 2019; Published: July 1, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Slíva J. Diosmin - still an important modality in the treatment of venous insufficiency. Vnitr Lek. 2019;65(7-8):524-526. doi: 10.36290/vnl.2019.091.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Diosmin. European Pharmacopoeia 8.3 2015; 4297-4298. Dostupné z WWW: <https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=2ahUKEwjFiebUjK_jAhVJSsAKHQctCK4QFjAAegQIARAC&url=http%3A%2F%2Fcdn.zhitiren.com%2Fuploads%2F1513840228%2FDiosmin_test_EP8.3.docx&usg=AOvVaw2HacGDz5zRMfZPZv5NicHm>.[22-1-2016.]
    2. Steinberg FM, Bearden MM, Keen CL. Cocoa and chocolate flavonoids: implications for cardiovascular health. J Am Diet Assoc 2003; 103(2): 215-223. Dostupné z DOI: <http://dx.doi.org/10.1053/jada.2003.50028>. Go to original source... Go to PubMed...
    3. Schewe T, Sadik C, Klotz LO et al. Polyphenols of cocoa: inhibition of mammalian 15-lipoxygenase. Biol Chem 2001; 382(12): 1687-1696. Dostupné z DOI: <http://dx.doi.org/10.1515/BC.2001.204>. Go to original source... Go to PubMed...
    4. Harnafi H, Amrani S. Flavonoids as Potent Phytochemicals in Cardiovascular Diseases Prevention. Pharmacognosy Reviews 2007; 1(2):193-202.
    5. Kanaze FI, Bounartzi MI, Georgarakis M et al. Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects. Eur J Clin Nutr 2007; 61(4): 472-477. Dostupné z DOI: <http://dx.doi.org/10.1038/sj.ejcn.1602543>. Go to original source... Go to PubMed...
    6. Cova D, De AL, Giavarini F et al. Pharmacokinetics and metabolism of oral diosmin in healthy volunteers. Int J Clin Pharmacol Ther Toxicol 1992; 30(1): 29-33.
    7. Villa P, Cova D, De FL et al. Protective effect of diosmetin on in vitro cell membrane damage and oxidative stress in cultured rat hepatocytes. Toxicology 1992; 73(2): 179-189. Go to original source... Go to PubMed...
    8. Diosmin Monograph. Altern Med Rev 2004; 9(3): 308-311.
    9. Diosmin Pharmconsul 500 mg. SPC 2016. Dostupné na WWW: <https://www.sukl.cz>.
    10. Chaumeil JC. Micronization: a method of improving the bioavailability of poorly soluble drugs. Methods Find.Exp Clin Pharmacol 1998; 20(3): 211-215. Go to original source...
    11. Garner RC, Garner JV, Gregory S et al. Comparison of the absorption of micronized (Daflon 500 mg) and nonmicronized 14C-diosmin tablets after oral administration to healthy volunteers by accelerator mass spectrometry and liquid scintillation counting. J Pharm Sci 2002; 91(1): 32-40. Dostupné z DOI: <http://dx.doi.org/10.1002/jps.1168>. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.